Delayed cord clamping and early skin-to-skin contact for premature infants
Preterm DElayed Cord Clamping and Early Skin-to-Skin Contact
This study is testing if waiting to cut the cord and having early skin-to-skin contact with parents can improve health and bonding for premature infants born between 30 and 34 weeks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 126 (estimated) |
| Ages | 30 Weeks to 34 Weeks |
| Sex | All |
| Sponsor | Ostergotland County Council, Sweden Academic / other |
| Locations | 1 site (Linköping) |
| Trial ID | NCT05709392 on ClinicalTrials.gov |
What this trial studies
The PreDECESS trial evaluates a new care method for premature infants born between 30 and 34 weeks gestation, focusing on delayed cord clamping and early skin-to-skin contact with parents. This prospective, multi-center study compares outcomes between infants receiving traditional care and those receiving the new method. Key areas of investigation include bonding, potential adverse effects, and various health indicators such as bilirubin levels and neurological development. The study aims to enhance the understanding of how these practices affect both infants and their parents.
Who should consider this trial
Good fit: Ideal candidates are premature infants born between 30+0 and 34+6 weeks gestation via vaginal delivery who are admitted to a neonatal ward in Sweden.
Not a fit: Patients with known diseases requiring early cord clamping or severe malformations may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could improve bonding between parents and their premature infants, leading to better developmental outcomes.
How similar studies have performed: Other studies have shown promising results with delayed cord clamping and skin-to-skin contact, suggesting potential benefits in similar approaches.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Infants born in gestational weeks 30+0-34+6 through vaginal delivery and admitted to neonatal ward in Sweden. Parents must be able to read Swedish. Exclusion Criteria: Infants with known disease when an expanded blood volume is expected will be excluded as early cord clamping is recommended (severe anemia, cardiac disease etc). Infants with known malformations. Infants with severe or moderate asphyxia (defined as APGAR \< 4 at 5 minutes of age). Infants where the physician in charge find it inappropriate with delayed cord clamping. No time for cord clamping has been registered.
Where this trial is running
Linköping
- Crown Princess Victoria children´s hopsital — Linköping, Sweden (Recruiting)
Study contacts
- Study coordinator: Thomas Abrahamsson, MD,PhD
- Email: thomas.abrahamsson@liu.se
- Phone: +46709566815
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.